Long-lasting correction of in vivo LTP and cognitive deficits of mice modelling Down syndrome with an α5-selective GABAA inverse agonist

  1. Duchon, A.
  2. Gruart, A.
  3. Albac, C.
  4. Delatour, B.
  5. Zorrilla de San Martin, J.
  6. Delgado-García, J.M.
  7. Hérault, Y.
  8. Potier, M.-C.
Journal:
British Journal of Pharmacology

ISSN: 1476-5381 0007-1188

Year of publication: 2020

Volume: 177

Issue: 5

Pages: 1106-1118

Type: Article

DOI: 10.1111/BPH.14903 GOOGLE SCHOLAR lock_openOpen access editor